Subscribe
Subscribe today to receive CGD’s latest newsletters and topic updates.
All Commentary
Filters:
Topics
Facet Toggle
Content Type
Facet Toggle
Blog Type
Facet Toggle
Time Frame
Facet Toggle
Blog Post
September 06, 2021
The need for effective evidence-informed priority-setting in global development is more urgent than ever, with widespread global challenges and reduced funding due to both COVID-19 related public spending and economic slowdowns. This blog explores three key barriers to using value for money evi...
Blog Post
July 26, 2021
In an accompanying blog we argue that girls’ education is unlikely to reduce future emissions, and that we should not think of girls in low-income countries as ‘assets’ to solve a climate crisis. But there is a link between education and climate change—it’s just the other way around. Here are f...
Blog Post
July 26, 2021
You might think girls' education and climate change are quite different issues. But, with money for and political attention on climate change growing, savvy education donors and advocacy organisations are increasingly making links between the two. The UK’s FCDO, for instance, claims girls in poor co...
Blog Post
July 19, 2021
The UK government is removing almost all COVID-19 restrictions from England in what the Prime Minister has as “Freedom Day”, but unfettered freedom does not exist. COVID is not going away any time soon. It’s time to prioritize transparency, consultation and long-term solutions. Everyone wa...
Blog Post
June 08, 2021
Vaccines have become a central instrument of our long-term response to the pandemic. Vaccination campaigns have now started around the world and will confer significant direct protection against infection, severe illness, and death to those inoculated. It may also protect against transmission, thoug...
Blog Post
June 04, 2021
Since March of 2020, COVID-19 changed most aspects of life as we knew it, from our personal day-to-day activities to the systems, processes, and structures that keep the global economy interconnected and moving. This included pharmaceutical production and distribution, where anecdotal evidence ...